{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T08:24:49Z","timestamp":1780734289206,"version":"3.54.1"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T00:00:00Z","timestamp":1735516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["88887.659679\/2021-00"],"award-info":[{"award-number":["88887.659679\/2021-00"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005672","name":"Funda\u00e7\u00e3o de Apoio ao Desenvolvimento do Ensino, Ci\u00eancia e Tecnologia do Estado de Mato Grosso do Sul","doi-asserted-by":"publisher","award":["155\/2024"],"award-info":[{"award-number":["155\/2024"]}],"id":[{"id":"10.13039\/501100005672","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-024-76480-0","type":"journal-article","created":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T18:28:35Z","timestamp":1735583315000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["The endocannabinoid system\u2019s genetic polymorphisms in sickle cell anemia patients"],"prefix":"10.1038","volume":"14","author":[{"given":"Amanda Cristina Meneguetti","family":"Berti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa da Silveira Ramos","family":"de Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela Silva","family":"Arcanjo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aderson","family":"da Silva Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Roberto","family":"Lucena-Araujo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos Andr\u00e9 Cavalcanti","family":"Bezerra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Gazarini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danilo Gr\u00fcnig Humberto","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edis","family":"Belini-J\u00fanior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,12,30]]},"reference":[{"key":"76480_CR1","doi-asserted-by":"publisher","first-page":"18010","DOI":"10.1038\/nrdp.2018.10","volume":"4","author":"GJ Kato","year":"2018","unstructured":"Kato, G. J. et al. Sickle cell disease. Nat. Rev. Dis. Prim. 4, 18010. https:\/\/doi.org\/10.1038\/nrdp.2018.10 (2018).","journal-title":"Nat. Rev. Dis. Prim."},{"issue":"10091","key":"76480_CR2","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S0140-6736(17)30193-9","volume":"390","author":"RE Ware","year":"2017","unstructured":"Ware, R. E., de Montalembert, M., Tshilolo, L. & Abboud, M. R. Sickle cell disease. Lancet. 390 (10091), 311\u2013323. https:\/\/doi.org\/10.1016\/S0140-6736(17)30193-9 (2017).","journal-title":"Lancet"},{"key":"76480_CR3","doi-asserted-by":"publisher","first-page":"2018","DOI":"10.1016\/S0140-6736(10)61029-X","volume":"376","author":"DC Rees","year":"2010","unstructured":"Rees, D. C., Williams, T. N. & Gladwin, M. T. Sickle-cell disease. Lancet. 376, 2018\u20132031. https:\/\/doi.org\/10.1016\/S0140-6736(10)61029-X (2010).","journal-title":"Lancet"},{"key":"76480_CR4","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1146\/annurev-bioeng-070909-105339","volume":"12","author":"GA Barabino","year":"2010","unstructured":"Barabino, G. A., Platt, M. O. & Kaul, D. K. Sickle cell biomechanics. Annu. Rev. Biomed. Eng. 12, 345\u2013367. https:\/\/doi.org\/10.1146\/annurev-bioeng-070909-105339 (2010).","journal-title":"Annu. Rev. Biomed. Eng."},{"issue":"3","key":"76480_CR5","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1172\/JCI89741","volume":"127","author":"GJ Kato","year":"2017","unstructured":"Kato, G. J., Steinberg, M. H. & Gladwin, M. T. Intravascular hemolysis and the pathophysiology of sickle cell disease. J. Clin. Invest. 127 (3), 750\u2013760. https:\/\/doi.org\/10.1172\/JCI89741 (2017).","journal-title":"J. Clin. Invest."},{"key":"76480_CR6","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1146\/annurev-genom-083117-021320","volume":"19","author":"TN Williams","year":"2018","unstructured":"Williams, T. N. & Thein, S. L. Sickle cell anemia and its phenotypes. Annu. Rev. Genomics Hum. Genet. 19, 113\u2013147. https:\/\/doi.org\/10.1146\/annurev-genom-083117-021320 (2018).","journal-title":"Annu. Rev. Genomics Hum. Genet."},{"issue":"5","key":"76480_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1038\/sj.ijir.3901077","volume":"15","author":"AL Burnett","year":"2003","unstructured":"Burnett, A. L. Priapism pathophysiology: Clues to prevention. Int. J. Impot. Res. 15 (5), 80\u201385. https:\/\/doi.org\/10.1038\/sj.ijir.3901077 (2003).","journal-title":"Int. J. Impot. Res."},{"issue":"9","key":"76480_CR8","doi-asserted-by":"publisher","first-page":"3264","DOI":"10.1182\/blood-2005-04-1594","volume":"106","author":"VG Nolan","year":"2005","unstructured":"Nolan, V. G., Wyszynski, D. F., Farrer, L. A. & Steinberg, M. H. Hemolysis-associated priapism in sickle cell disease. Blood. 106 (9), 3264\u20133267. https:\/\/doi.org\/10.1182\/blood-2005-04-1594 (2005).","journal-title":"Blood"},{"issue":"1","key":"76480_CR9","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1111\/j.1743-6109.2011.02317.x","volume":"9","author":"GA Broderick","year":"2012","unstructured":"Broderick, G. A. Priapism and sickle-cell Anemia: diagnosis and nonsurgical therapy. J. Sex. Med. 9 (1), 88\u2013103. https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02317.x (2012).","journal-title":"J. Sex. Med."},{"key":"76480_CR10","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.urology.2021.06.010","volume":"156","author":"G Ahuja","year":"2021","unstructured":"Ahuja, G. et al. Priapism and Sickle Cell Disease: Special considerations in Etiology, Management, and Prevention. Urology. 156, 40\u201347. https:\/\/doi.org\/10.1016\/j.urology.2021.06.010 (2021).","journal-title":"Urology"},{"issue":"5","key":"76480_CR11","doi-asserted-by":"publisher","first-page":"474","DOI":"10.2174\/1389450115666141111111842","volume":"16","author":"UA Anele","year":"2015","unstructured":"Anele, U. A., Morrison, B. F. & Burnett, A. L. Molecular Pathophysiology of Priapism: emerging targets. Curr. Drug Targets. 16 (5), 474\u2013483. https:\/\/doi.org\/10.2174\/1389450115666141111111842 (2015).","journal-title":"Curr. Drug Targets"},{"issue":"4","key":"76480_CR12","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.bcmd.2015.01.011","volume":"54","author":"E Belini-J\u00fanior","year":"2015","unstructured":"Belini-J\u00fanior, E. et al. The severity of Brazilian sickle cell disease patients: severity scores and feasibility of the bayesian network model use. Blood Cells Mol. Dis. 54 (4), 321\u2013327. https:\/\/doi.org\/10.1016\/j.bcmd.2015.01.011 (2015).","journal-title":"Blood Cells Mol. Dis."},{"key":"76480_CR13","doi-asserted-by":"publisher","first-page":"100983","DOI":"10.1016\/j.blre.2022.100983","volume":"56","author":"DC Rees","year":"2022","unstructured":"Rees, D. C., Brousse, V. A. M. & Brewin, J. N. Determinants of severity in sickle cell disease. Blood Rev. 56, 100983. https:\/\/doi.org\/10.1016\/j.blre.2022.100983 (2022).","journal-title":"Blood Rev."},{"key":"76480_CR14","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1038\/nrd.2018.115","volume":"17","author":"V Di Marzo","year":"2018","unstructured":"Di Marzo, V. New approaches and challenges to targeting the endocannabinoid system. Nat. Rev. Drug Discov. 17, 623\u2013639. https:\/\/doi.org\/10.1038\/nrd.2018.115 (2018).","journal-title":"Nat. Rev. Drug Discov"},{"issue":"1","key":"76480_CR15","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41582-019-0284-z","volume":"16","author":"L Cristino","year":"2020","unstructured":"Cristino, L., Bisogno, T. & Di Marzo, V. Cannabinoids and the expanded endocannabinoid system in neurological disorders. Nat. Rev. Neurol. 16 (1), 9\u201329. https:\/\/doi.org\/10.1038\/s41582-019-0284-z (2020).","journal-title":"Nat. Rev. Neurol."},{"issue":"14","key":"76480_CR16","doi-asserted-by":"publisher","first-page":"1430","DOI":"10.2174\/092986710790980078","volume":"17","author":"V Di Marzo","year":"2010","unstructured":"Di Marzo, V. & De Petrocellis, L. Endocannabinoids as regulators of transient receptor potential (TRP) channels: A further opportunity to develop New Endocannabinoid-based therapeutic drugs. Curr. Med. Chem. 17 (14), 1430\u20131449. https:\/\/doi.org\/10.2174\/092986710790980078 (2010).","journal-title":"Curr. Med. Chem."},{"key":"76480_CR17","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.plipres.2016.02.002","volume":"62","author":"FA Iannotti","year":"2016","unstructured":"Iannotti, F. A., Di Marzo, V. & Petrosino, S. Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism, and role in neurological disorders. Prog Lipid Res. 62, 107\u2013128. https:\/\/doi.org\/10.1016\/j.plipres.2016.02.002 (2016).","journal-title":"Prog Lipid Res."},{"key":"76480_CR18","doi-asserted-by":"publisher","first-page":"586","DOI":"10.3390\/cells10030586","volume":"10","author":"FA Iannotti","year":"2021","unstructured":"Iannotti, F. A. & Vitale, R. M. The Endocannabinoid System and PPARs: Focus on their Signalling Crosstalk, Action and Transcriptional Regulation. Cells. 10, 586. https:\/\/doi.org\/10.3390\/cells10030586 (2021).","journal-title":"Cells"},{"key":"76480_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1177\/20406223221143239","volume":"14","author":"S Dziemitko","year":"2023","unstructured":"Dziemitko, S., Harasim-Symbor, E. & Chabowski, A. How do phytocannabinoids affect cardiovascular health? An update on the most common cardiovascular disease. Ther. Adv. Chronic Dis. 14, 1\u201318. https:\/\/doi.org\/10.1177\/20406223221143239 (2023).","journal-title":"Ther. Adv. Chronic Dis."},{"key":"76480_CR20","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1159\/000110714","volume":"20","author":"PJ Bentzen","year":"2007","unstructured":"Bentzen, P. J. & Lang, F. Effect of Anandamide on Erythrocyte Survival. Cell. Physiol. Biochem. 20, 1033\u20131042. https:\/\/doi.org\/10.1159\/000110714 (2007).","journal-title":"Cell. Physiol. Biochem."},{"key":"76480_CR21","doi-asserted-by":"publisher","unstructured":"De Angelis, V. et al. Endocannabinoids control platelet activation and limit aggregate formation under Flow. PLoS ONE. 9 (9). https:\/\/doi.org\/10.1371\/journal.pone.0108282 (2014). e108282.","DOI":"10.1371\/journal.pone.0108282"},{"key":"76480_CR22","doi-asserted-by":"publisher","first-page":"3235","DOI":"10.1007\/s00018-015-1924-0","volume":"72","author":"V Gasperi","year":"2015","unstructured":"Gasperi, V. et al. Downstream effects of endocannabinoid on blood cells: implications for health and disease. Cell. Mol. Life Sci. 72, 3235\u20133252. https:\/\/doi.org\/10.1007\/s00018-015-1924-0 (2015).","journal-title":"Cell. Mol. Life Sci."},{"key":"76480_CR23","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1007\/s11481-007-9077-z","volume":"3","author":"ES Raborn","year":"2008","unstructured":"Raborn, E. S., Marciano-Cabral, F., Buckley, N. E., Martin, B. R. & Cabral, G. A. The Cannabinoid Delta-9-tetrahydrocannabinol mediates inhibition of Macrophage Chemotaxis to RANTES\/CCL5: linkage to the CB2 receptor. J. Neuroimmune Pharmacol. 3, 117\u2013129. https:\/\/doi.org\/10.1007\/s11481-007-9077-z (2008).","journal-title":"J. Neuroimmune Pharmacol."},{"key":"76480_CR24","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1097\/FJC.0b013e3181d2644d","volume":"55","author":"Y Zhao","year":"2010","unstructured":"Zhao, Y. et al. Activation of cannabinoid CB2 receptor ameliorates atherosclerosis Associated with suppression of Adhesion molecules. J. Cardiovasc. Pharmacol. 55, 292\u2013298. https:\/\/doi.org\/10.1097\/FJC.0b013e3181d2644d (2010).","journal-title":"J. Cardiovasc. Pharmacol."},{"key":"76480_CR25","unstructured":"Brasil Minist\u00e9rio da Sa\u00fade. Secretaria de Aten\u00e7\u00e3o \u00e0 Sa\u00fade. Secretaria de Ci\u00eancia, Tecnologia e Insumos Estrat\u00e9gicos. Portaria Conjunta SAS\/SCTIE\/MS n\u00ba 05\u201319\/02\/2018. Protocolo Cl\u00ednico e Diretrizes Terap\u00eauticas da Doen\u00e7a Falciforme. (2018). https:\/\/www.gov.br\/conitec\/pt-br\/midias\/protocolos\/pcdt_doencafalciforme_2018-1.pdf"},{"key":"76480_CR26","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1097\/01.ju.0000087608.07371.ca","volume":"170","author":"DK Montague","year":"2003","unstructured":"Montague, D. K. et al. American Urological Association guideline on the management of priapism. J. Urol. 170, 1318\u20131324. https:\/\/doi.org\/10.1097\/01.ju.0000087608.07371.ca (2003).","journal-title":"J. Urol."},{"issue":"2\u20133","key":"76480_CR27","doi-asserted-by":"publisher","first-page":"105","DOI":"10.3233\/CH-189002","volume":"68","author":"SK Ballas","year":"2018","unstructured":"Ballas, S. K. Sickle cell disease: classification of clinical complications and approaches to preventive and therapeutic management. Clin. Hemorheol Microcirc. 68 (2\u20133), 105\u2013128. https:\/\/doi.org\/10.3233\/CH-189002 (2018).","journal-title":"Clin. Hemorheol Microcirc"},{"key":"76480_CR28","unstructured":"Sambrook, J. & Russell, D. W. Molecular Cloning: A Laboratory Manual 1st edn (Cold Spring Harbor Laboratory Press, 2001)."},{"key":"76480_CR29","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1126\/science.2999980","volume":"230","author":"RK Saiki","year":"1985","unstructured":"Saiki, R. K. et al. Enzymatic amplification of Beta-globin genomic sequences and restriction site analysis for diagnosis of sickle-cell Anemia. Science. 230, 1350\u20131354. https:\/\/doi.org\/10.1126\/science.2999980 (1985).","journal-title":"Science"},{"issue":"1","key":"76480_CR30","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1182\/blood.V95.1.360","volume":"95","author":"SS Chong","year":"2000","unstructured":"Chong, S. S., Boehm, C. D., Higgs, D. R. & Cutting, G. R. Single-tube multiplex-PCR screen for common deletional determinants of \u03b1-thalassemia. Blood. 95 (1), 360\u2013362. https:\/\/doi.org\/10.1182\/blood.V95.1.360 (2000).","journal-title":"Blood"},{"issue":"18","key":"76480_CR31","doi-asserted-by":"publisher","first-page":"2113","DOI":"10.1093\/hmg\/ddh216","volume":"13","author":"KP Chiang","year":"2004","unstructured":"Chiang, K. P., Gerber, A. L., Sipe, J. C. & Cravatt, B. F. Reduced cellular expression and activity of the P129T mutant of human fatty acid amide hydrolase: evidence for a link between defects in the endocannabinoid system and problem drug use. Hum. Mol. Genet. 13 (18), 2113\u20132119. https:\/\/doi.org\/10.1093\/hmg\/ddh216 (2004).","journal-title":"Hum. Mol. Genet."},{"issue":"8","key":"76480_CR32","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1007\/s00406-021-01367-4","volume":"272","author":"J Spohrs","year":"2022","unstructured":"Spohrs, J., Ulrich, M., Gr\u00f6n, G., Plener, P. L. & Abler, B. FAAH polymorphism (rs324420) modulates extinction recall in healthy humans: an fMRI study. Eur. Arch. Psychiatry Clin. Neurosci. 272 (8), 1495\u20131504. https:\/\/doi.org\/10.1007\/s00406-021-01367-4 (2022).","journal-title":"Eur. Arch. Psychiatry Clin. Neurosci."},{"issue":"4","key":"76480_CR33","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1037\/abn0000079","volume":"124","author":"CE Carey","year":"2015","unstructured":"Carey, C. E. et al. Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: evidence from an endocannabinoid system-level analysis. J. Abnorm. Psychol. 124 (4), 860\u2013877. https:\/\/doi.org\/10.1037\/abn0000079 (2015).","journal-title":"J. Abnorm. Psychol."},{"issue":"3","key":"76480_CR34","doi-asserted-by":"publisher","first-page":"226","DOI":"10.47626\/1516-4446-2022-2882","volume":"45","author":"CM Loureiro","year":"2023","unstructured":"Loureiro, C. M. et al. Lifetime cannabis use and childhood trauma increase risk of psychosis in carriers of CNR1 genetic variants: findings from the STREAM study. Braz J. Psychiatry. 45 (3), 226\u2013235. https:\/\/doi.org\/10.47626\/1516-4446-2022-2882 (2023).","journal-title":"Braz J. Psychiatry"},{"issue":"3","key":"76480_CR35","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/FPC.0b013e3283367c6b","volume":"20","author":"A Carrasquer","year":"2010","unstructured":"Carrasquer, A., Nebane, N. M., Williams, W. M. & Zhao-Hui, S. Functional consequences of nonsynonymous single nucleotide polymorphisms in the CB2 cannabinoid receptor. Pharmacogenet Genomics. 20 (3), 157\u2013166. https:\/\/doi.org\/10.1097\/FPC.0b013e3283367c6b (2010).","journal-title":"Pharmacogenet Genomics"},{"issue":"1","key":"76480_CR36","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1007\/s12031-019-01395-9","volume":"70","author":"A Tahamtan","year":"2020","unstructured":"Tahamtan, A. et al. Cannabinoid CB2 receptor functional variation (Q63R) is Associated with multiple sclerosis in Iranian subjects. J. Mol. Neurosci. 70 (1), 26\u201331. https:\/\/doi.org\/10.1007\/s12031-019-01395-9 (2020).","journal-title":"J. Mol. Neurosci."},{"issue":"11","key":"76480_CR37","doi-asserted-by":"publisher","first-page":"3117","DOI":"10.1007\/s00705-021-05223-7","volume":"166","author":"M Rastegar","year":"2021","unstructured":"Rastegar, M. et al. Functional variation (Q63R) in the cannabinoid CB2 receptor may affect the severity of COVID-19: A human study and molecular docking. Arch. Virol. 166 (11), 3117\u20133126. https:\/\/doi.org\/10.1007\/s00705-021-05223-7 (2021).","journal-title":"Arch. Virol."},{"key":"76480_CR38","unstructured":"dbSNP [Internet]. Bethesda (MD). National Library of Medicine (US), National Center for Biotechnology Information; 1999 \u2013 [cited 2024 Mar 12] https:\/\/www.ncbi.nlm.nih.gov\/snp\/"},{"issue":"6","key":"76480_CR39","doi-asserted-by":"publisher","first-page":"1097","DOI":"10.1016\/j.hoc.2022.06.006","volume":"36","author":"T Pincez","year":"2022","unstructured":"Pincez, T., Ashley-Koch, A. E., Lettre, G. & Telen, M. J. Genetic modifiers of Sickle Cell Disease. Hematol. \/Oncol Clin. N Am. 36 (6), 1097\u20131124. https:\/\/doi.org\/10.1016\/j.hoc.2022.06.006 (2022).","journal-title":"Hematol. \/Oncol Clin. N Am."},{"issue":"6","key":"76480_CR40","doi-asserted-by":"publisher","first-page":"516","DOI":"10.3109\/03630269.2010.526003","volume":"34","author":"AR Belis\u00e1rio","year":"2010","unstructured":"Belis\u00e1rio, A. R., Rodrigues, C. V., Martins, M. L., Silva, C. M. & Viana, M. B. Coinheritance of \u03b1-thalassemia decreases the risk of cerebrovascular disease in a cohort of children with sickle cell anemia. Hemoglobin. 34 (6), 516\u2013529. https:\/\/doi.org\/10.3109\/03630269.2010.526003 (2010).","journal-title":"Hemoglobin"},{"issue":"1","key":"76480_CR41","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3233\/CH-131772","volume":"57","author":"Y Lamarre","year":"2014","unstructured":"Lamarre, Y. et al. Alpha Thalassemia protects sickle cell anemia patients from macro-albuminuria through its effects on red blood cell rheological properties. Clin. Hemorheol Microcirc. 57 (1), 63\u201372. https:\/\/doi.org\/10.3233\/CH-131772 (2014).","journal-title":"Clin. Hemorheol Microcirc"},{"issue":"7","key":"76480_CR42","doi-asserted-by":"publisher","first-page":"5397","DOI":"10.1007\/s11033-020-05628-8","volume":"47","author":"B Santos","year":"2020","unstructured":"Santos, B. et al. Co-inheritance of alpha-thalassemia and sickle cell disease in a cohort of Angolan pediatric patients. Mol. Biol. Rep.47 (7), 5397\u20135402. https:\/\/doi.org\/10.1007\/s11033-020-05628-8 (2020).","journal-title":"Mol. Biol. Rep."},{"issue":"9","key":"76480_CR43","doi-asserted-by":"publisher","first-page":"E762","DOI":"10.1097\/HS9.0000000000000762","volume":"6","author":"SE Hoss","year":"2022","unstructured":"Hoss, S. E., Nemer, W. E. & Rees, D. C. Precision Medicine and Sickle Cell Disease. Hemasphere. 6 (9), E762. https:\/\/doi.org\/10.1097\/HS9.0000000000000762 (2022).","journal-title":"Hemasphere"},{"issue":"1","key":"76480_CR44","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.blre.2006.07.001","volume":"21","author":"GJ Kato","year":"2007","unstructured":"Kato, G. J., Gladwin, M. T. & Steinberg, M. H. Deconstructing sickle cell disease: reappraisal of the role of hemolysis in the development of clinical subphenotypes. Blood Rev. 21 (1), 37\u201347. https:\/\/doi.org\/10.1016\/j.blre.2006.07.001 (2007).","journal-title":"Blood Rev."},{"issue":"2","key":"76480_CR45","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1002\/cphy.c200024","volume":"11","author":"E Nader","year":"2021","unstructured":"Nader, E., Conran, N., Romana, M. & Connes, P. Vasculopathy in Sickle Cell Disease: from Red Blood Cell Sickling to Vascular Dysfunction. Compr. Physiol. 11 (2), 1785\u20131803. https:\/\/doi.org\/10.1002\/cphy.c200024 (2021).","journal-title":"Compr. Physiol."},{"key":"76480_CR46","doi-asserted-by":"publisher","unstructured":"Hurt, K. J. et al. Akt-dependent phosphorylation of endothelial nitric-oxide synthase mediates penile erection. Proc. Natl. Acad. Sci. USA. 99(6), 4061\u20134066 (2002). https:\/\/doi.org\/10.1073\/pnas.052712499","DOI":"10.1073\/pnas.052712499"},{"issue":"1","key":"76480_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1743-6109.2011.02288.x","volume":"9","author":"TJ Bivalacqua","year":"2012","unstructured":"Bivalacqua, T. J., Musicki, B., Kutlu, O. & Burnett, A. L. New insights into the pathophysiology of Sickle Cell Disease-Associated Priapism. J. Sex. Med.Bold\">9 (1), 79\u201387. https:\/\/doi.org\/10.1111\/j.1743-6109.2011.02288.x (2012).","journal-title":"J. Sex. Med."},{"issue":"5","key":"76480_CR48","doi-asserted-by":"publisher","first-page":"1661","DOI":"10.1073\/pnas.0407183102","volume":"102","author":"HC Champion","year":"2005","unstructured":"Champion, H. C., Bivalacqua, T. J., Takimoto, E., Kass, D. A. & Burnett, A. L. Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism. Proc. Natl. Acad. Sci. USA. 102 (5), 1661\u20131666. https:\/\/doi.org\/10.1073\/pnas.0407183102 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"5","key":"76480_CR49","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1080\/14728222.2020.1745188","volume":"24","author":"B Musicki","year":"2020","unstructured":"Musicki, B. & Burnett, A. L. Mechanisms underlying priapism in sickle cell disease: targeting and key innovations on the preclinical landscape. Expert Opin. Ther. Targets. 24 (5), 439\u2013450. https:\/\/doi.org\/10.1080\/14728222.2020.1745188 (2020).","journal-title":"Expert Opin. Ther. Targets"},{"issue":"2","key":"76480_CR50","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/j.1743-6109.2010.02123.x","volume":"8","author":"B Musicki","year":"2011","unstructured":"Musicki, B., Champion, H. C., Hsu, L. L., Bivalacqua, T. J. & Burnett, A. L. Post-translational inactivation of endothelial nitric oxide synthase in the transgenic sickle cell mouse Penis. J. Sex. Med. 8 (2), 419\u2013426. https:\/\/doi.org\/10.1111\/j.1743-6109.2010.02123.x (2011).","journal-title":"J. Sex. Med."},{"issue":"8","key":"76480_CR51","doi-asserted-by":"publisher","first-page":"1980","DOI":"10.1111\/j.1743-6109.2012.02798.x","volume":"9","author":"B Musicki","year":"2012","unstructured":"Musicki, B., Liu, T., Sezen, S. F., Burnett, A. L. & Targeting NADPH oxidase decreases oxidative stress in the transgenic sickle cell mouse Penis. J. Sex. Med.9 (8), 1980\u20131987. https:\/\/doi.org\/10.1111\/j.1743-6109.2012.02798.x (2012).","journal-title":"J. Sex. Med."},{"issue":"7","key":"76480_CR52","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1371\/journal.pone.0068028","volume":"8","author":"TJ Bivalacqua","year":"2013","unstructured":"Bivalacqua, T. J. et al. Sildenafil citrate-restored eNOS and PDE5 regulation in Sickle Cell Mouse Penis prevents Priapism Via Control of Oxidative\/Nitrosative stress. PLoS ONE. 8 (7), 3\u201310. https:\/\/doi.org\/10.1371\/journal.pone.0068028 (2013).","journal-title":"PLoS ONE"},{"issue":"2","key":"76480_CR53","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/jsm.12391","volume":"11","author":"B Musicki","year":"2014","unstructured":"Musicki, B., Bivalacqua, T. J., Champion, H. C. & Burnett, A. L. Sildenafil promotes eNOS activation and inhibits NADPH oxidase in the transgenic sickle cell mouse penis. J. Sex. Med. 11 (2), 424\u2013430. https:\/\/doi.org\/10.1111\/jsm.12391 (2014).","journal-title":"J. Sex. Med."},{"issue":"12","key":"76480_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1371\/journal.pone.0166291","volume":"11","author":"FH Silva","year":"2016","unstructured":"Silva, F. H. et al. Sympathetic hyperactivity, increased tyrosine hydroxylase and exaggerated corpus cavernosum relaxations associated with oxidative stress plays a major role in the penis dysfunction in Townes sickle cell mouse. PLoS ONE. 11 (12), 1\u201317. https:\/\/doi.org\/10.1371\/journal.pone.0166291 (2016).","journal-title":"PLoS ONE"},{"issue":"11","key":"76480_CR55","doi-asserted-by":"publisher","first-page":"622","DOI":"10.1038\/nrurol.2014.278","volume":"11","author":"N Sopko","year":"2014","unstructured":"Sopko, N., Hannan, J. & Bivalacqua, T. Understanding and targeting the rho kinase pathway in erectile dysfunction. Nat. Rev. Urol. 11 (11), 622\u2013628. https:\/\/doi.org\/10.1038\/nrurol.2014.278 (2014).","journal-title":"Nat. Rev. Urol."},{"key":"76480_CR56","doi-asserted-by":"publisher","unstructured":"Bivalacqua, T. J. et al. Attenuated rhoA\/rho-kinase signaling in penis of transgenic sickle cell mice. Urology. 76(2), 510.e7-510.e12 (2010). https:\/\/doi.org\/10.1016\/j.urology.2010.02.050","DOI":"10.1016\/j.urology.2010.02.050"},{"issue":"2","key":"76480_CR57","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1016\/j.juro.2012.08.198","volume":"189","author":"G Lagoda","year":"2013","unstructured":"Lagoda, G., Sezen, S. F., Cabrini, M. R., Musicki, B. & Burnett, A. L. Molecular Analysis of Erection Regulatory Factors in Sickle Cell Disease Associated Priapism in the human penis. J. Urol. 189 (2), 762\u2013768. https:\/\/doi.org\/10.1016\/j.juro.2012.08.198 (2013).","journal-title":"J. Urol."},{"key":"76480_CR58","doi-asserted-by":"publisher","first-page":"H2210","DOI":"10.1152\/ajpheart.00688.2007","volume":"293","author":"M Rajesh","year":"2007","unstructured":"Rajesh, M. et al. CB2-receptor stimulation attenuates TNF-\u03b1-induced human endothelial cell activation, transendothelial migration of monocytes, and monocyte-endothelial adhesion. Am. J. Physiol. Heart Circ. Physiol. 293, H2210\u2013H2218. https:\/\/doi.org\/10.1152\/ajpheart.00688.2007 (2007).","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"key":"76480_CR59","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1476-5381.2010.00729.x","volume":"160","author":"BK Atwood","year":"2010","unstructured":"Atwood, B. K. & Mackie, K. CB2: a cannabinoid receptor with an identity crisis. Br. J. Pharmacol. 160, 467\u2013479. https:\/\/doi.org\/10.1111\/j.1476-5381.2010.00729.x (2010).","journal-title":"Br. J. Pharmacol."},{"key":"76480_CR60","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.jchemneu.2014.06.004","volume":"59","author":"MJ Dowie","year":"2014","unstructured":"Dowie, M. J., Grimsey, N. L., Hoffman, T., Faull, R. L. M. & Glass, M. Cannabinoid receptor CB2 is expressed on vascular cells, but not astroglial cells in the post-mortem human Huntington\u2019s disease brain. J. Chem. Neuroanat. 59, 62\u201371. https:\/\/doi.org\/10.1016\/j.jchemneu.2014.06.004 (2014).","journal-title":"J. Chem. Neuroanat."},{"key":"76480_CR61","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1016\/j.pnpbp.2011.12.001","volume":"38","author":"BK Atwood","year":"2012","unstructured":"Atwood, B. K., Straiker, A. & Mackie, K. CB2: therapeutic target-in-waiting. Prog Neuro-Psychopharmacol Biol. Psychiatry. 38, 16\u201320. https:\/\/doi.org\/10.1016\/j.pnpbp.2011.12.001 (2012).","journal-title":"Prog Neuro-Psychopharmacol Biol. Psychiatry"},{"key":"76480_CR62","doi-asserted-by":"publisher","unstructured":"Matta, A., Tandra, P. K. & Berim, L. Priapism in a patient with sickle cell trait using marijuana. BMJ Case Rep. bcr2014204199 (2014). https:\/\/doi.org\/10.1136\/bcr-2014-204199","DOI":"10.1136\/bcr-2014-204199"},{"issue":"5","key":"76480_CR63","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1089\/gtmb.2018.0005","volume":"22","author":"J Wang","year":"2018","unstructured":"Wang, J. et al. Genetic variant Q63R of cannabinoid receptor 2 causes Differential ERK Phosphorylation in Human Immune cells. Genet. Test. Mol. Biomarkers. 22 (5), 320\u2013326. https:\/\/doi.org\/10.1089\/gtmb.2018.0005 (2018).","journal-title":"Genet. Test. Mol. Biomarkers"},{"issue":"12","key":"76480_CR64","doi-asserted-by":"publisher","first-page":"3902","DOI":"10.3390\/jcm9123902","volume":"9","author":"DA Argueta","year":"2020","unstructured":"Argueta, D. A. et al. Considerations for Cannabis Use to treat Pain in Sickle Cell Disease. J. Clin. Med. 9 (12), 3902. https:\/\/doi.org\/10.3390\/jcm9123902 (2020).","journal-title":"J. Clin. Med."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76480-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76480-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76480-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,31]],"date-time":"2024-12-31T09:05:39Z","timestamp":1735635939000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-024-76480-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12,30]]},"references-count":64,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2024,12]]}},"alternative-id":["76480"],"URL":"https:\/\/doi.org\/10.1038\/s41598-024-76480-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,12,30]]},"assertion":[{"value":"3 April 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 October 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 December 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was performed in line with the principles of the Declaration of Helsinki. Approval was granted by the Federal University of Pernambuco Ethics Committee and Hemotherapy Foundation of Pernambuco (CAAE: 58863316.6.3001.5195).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics statement"}}],"article-number":"31562"}}